IsoPlexis Receives $2 Million National Cancer Institute Grant to Target the Functional Pathways in Rare Cancer Cells that Drive Resistance

/in , /by

IsoPlexis continues to build its pipeline of revolutionary, single-cell, proteomic biology solutions with novel, tumor cell, proteomic signaling pathway technology BRANFORD, Conn. — IsoPlexis, the leading life sciences company in the single-cell proteomics space, announced today that it has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center for […]

Read more →

Ovizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation

/in , /by

Brussels, Belgium – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today announces the execution of supply agreements with Celgene Corporation for the automation of certain engineered T cell manufacturing processes. Celgene will be using Ovizio’s innovative on-line iLine F microscope, and the BioConnect system, a closed, single-use fluidic […]

Read more →

“Dolomite Microfluidics offers new microfluidic chips for Telos® system”

/in , , , /by

Dolomite Microfluidics has launched a number of new microfluidic chip options for its innovative Telos® system. The expanded range of high quality glass chips is intended to open up a number of new applications for the high-throughput Telos platform, providing a genuinely scalable option for droplet, particle and flow product generation across a wide range of industries. The expanded range now includes a 50 μm version of the Telos 2 Reagent Chip to complement […]

Read more →

Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials

/in , /by

Newly Allowed Patent Covers use of the CertainT ® Platform in Cellulosic Fibers and Materials including Rayon; Company Currently in Discussions with Leading Manufacturers STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that […]

Read more →

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process

/in , , , , , /by

WASHINGTON — Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses, which are part of Danaher’s Life Sciences segment, was approximately $140 million in 2018. Danaher […]

Read more →

Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering

/in , /by

SAN DIEGO — BIONANO GENOMICS, INC. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced the pricing of an underwritten public offering of 20,937,558 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) […]

Read more →

Thermo Fisher Scientific Launches Cell Culture Media as First to Remain Stable When Stored at Room Temperature

/in , , , /by

Storing at room temperature offers labs greater flexibility and requires less energy CARLSBAD, Calif. — For biological researchers looking to reduce their reliance on cold storage without disrupting their existing workflow, Thermo Fisher Scientific’s new cell culture media are the first to remain stable at room temperature. Gibco BenchStable Media are the latest offering in the […]

Read more →

MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform

/in , /by

Results from early access collaborators show high quality and reproducibility HOUSTON — MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS™ proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS). MGI also reported that […]

Read more →